| Mr Rickey Ladon Hutcheson, DO | |
|
2350 North Ocoee Street, Cleveland, TN 37311 | |
| (423) 476-5554 | |
| (423) 614-6116 |
| Full Name | Mr Rickey Ladon Hutcheson |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 33 Years |
| Location | 2350 North Ocoee Street, Cleveland, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093740367 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | DO1134 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health Chattanooga | Chattanooga, TN | Home health agency |
| Guardian Home Care, Llc | Chattanooga, TN | Home health agency |
| Tennova Health Care-cleveland | Cleveland, TN | Hospital |
| Starr Regional Medical Center Athens | Athens, TN | Hospital |
| Memorial Healthcare System, Inc | Chattanooga, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tennessee Valley Bone And Joint Llc | 6800985102 | 8 |
News Archive
An expert committee have recommended that the U.S. government allows the clinical investigation of mitochondrial replacement techniques (MRT) to go ahead.
New research into the treatment and prognosis of gastrointestinal cancers was released today in advance of the tenth annual Gastrointestinal Cancers Symposium being held January 24-26, 2013, at The Moscone West Building in San Francisco, CA.
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.
GlaxoSmithKline today announced that the United States Food and Drug Administration granted full approval for PROMACTA, an oral tablet that can raise platelet counts in patients with the rare blood disorder chronic immune thrombocytopenic purpura who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy.
› Verified 5 days ago
| Entity Name | Tennessee Valley Bone And Joint Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801084884 PECOS PAC ID: 6800985102 Enrollment ID: O20071210000602 |
News Archive
An expert committee have recommended that the U.S. government allows the clinical investigation of mitochondrial replacement techniques (MRT) to go ahead.
New research into the treatment and prognosis of gastrointestinal cancers was released today in advance of the tenth annual Gastrointestinal Cancers Symposium being held January 24-26, 2013, at The Moscone West Building in San Francisco, CA.
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.
GlaxoSmithKline today announced that the United States Food and Drug Administration granted full approval for PROMACTA, an oral tablet that can raise platelet counts in patients with the rare blood disorder chronic immune thrombocytopenic purpura who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Rickey Ladon Hutcheson, DO 3024 Business Park Cir, Goodlettsville, TN 37072-3132 Ph: (615) 239-2018 | Mr Rickey Ladon Hutcheson, DO 2350 North Ocoee Street, Cleveland, TN 37311 Ph: (423) 476-5554 |
News Archive
An expert committee have recommended that the U.S. government allows the clinical investigation of mitochondrial replacement techniques (MRT) to go ahead.
New research into the treatment and prognosis of gastrointestinal cancers was released today in advance of the tenth annual Gastrointestinal Cancers Symposium being held January 24-26, 2013, at The Moscone West Building in San Francisco, CA.
Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.
GlaxoSmithKline today announced that the United States Food and Drug Administration granted full approval for PROMACTA, an oral tablet that can raise platelet counts in patients with the rare blood disorder chronic immune thrombocytopenic purpura who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy.
› Verified 5 days ago
Dr. Garrick W. Cason, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 102 Dunhill Pl Nw, Ste A, Cleveland, TN 37311 Phone: 423-728-1650 Fax: 423-728-1655 | |
Jason Ronald Spangler, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2400 N Ocoee St, Cleveland, TN 37311 Phone: 423-624-2696 | |
Dr. James M Osborn, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 102 Dunhill Pl Nw, Suite A, Cleveland, TN 37311 Phone: 423-728-1650 Fax: 423-728-1655 | |
Dr. Lee M Radford, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2350 N Ocoee Street, Cleveland, TN 37311 Phone: 423-476-5554 Fax: 423-614-6116 | |
Gary J Voytik, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2700 Westside Dr Nw, Suite 301, Cleveland, TN 37312 Phone: 423-479-3600 Fax: 423-303-1234 |